VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HEIMBERGER, AMY B
One or more keywords matched the following items that are connected to
HEIMBERGER, AMY B
Item Type
Name
Academic Article
A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
Academic Article
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.
Academic Article
EGFRvIII-targeted vaccination therapy of malignant glioma.
Academic Article
Clinical applications of a peptide-based vaccine for glioblastoma.
Academic Article
Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Academic Article
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
Academic Article
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.
Academic Article
Topotecan enhances immune clearance of gliomas.
Academic Article
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?
Academic Article
Immunotherapy for human glioma: innovative approaches and recent results.
Academic Article
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.
Academic Article
The role of tregs in glioma-mediated immunosuppression: potential target for intervention.
Concept
Immunotherapy
Concept
Immunotherapy, Adoptive
Academic Article
Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.
Academic Article
Epidermal growth factor receptor and variant III targeted immunotherapy.
Academic Article
Immunotherapy for primary brain tumors: no longer a matter of privilege.
Academic Article
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity.
Academic Article
Immunosuppressive mechanisms in glioblastoma.
Academic Article
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.
Academic Article
Synergistic effect of immunotherapy and chemotherapy in cancers
Academic Article
Cytomegalovirus-targeted immunotherapy and glioblastoma
Academic Article
Principles of immunotherapy
Academic Article
Redirecting T-cell specificity to EGFR using mRNA to self-limit expression of chimeric antigen receptor
Academic Article
Prioritization schema for immunotherapy clinical trials in glioblastoma
Academic Article
Erratum
Academic Article
Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
Academic Article
Principles of immunotherapy.
Academic Article
Immunotherapy in glioblastoma: emerging options in precision medicine.
Academic Article
Prioritization schema for immunotherapy clinical trials in glioblastoma.
Academic Article
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.
Academic Article
Immune Checkpoint Inhibitors for Brain Metastases.
Academic Article
Tumor Vaccines for Malignant Gliomas.
Academic Article
Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function.
Academic Article
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Academic Article
Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?
Academic Article
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Academic Article
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
Academic Article
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Academic Article
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Academic Article
The immune landscape of common CNS malignancies: implications for immunotherapy.
Academic Article
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy.
Academic Article
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
Academic Article
New Approaches to Glioblastoma.
Academic Article
The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
Academic Article
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Academic Article
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Academic Article
Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment.
Academic Article
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment.
Academic Article
Next Steps for Immunotherapy in Glioblastoma.
Academic Article
Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors.
Academic Article
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease.
Academic Article
Aspirin and immunotherapy: a Faustian bargain?
Academic Article
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
Search Criteria
Immunotherapy